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ABSTRACT 
SNPs are DNA sequence variations occurring when a nucleotide in the genome differs between 
members of a species. These are the most frequent types of genetic variations, accounting for 
about 90 % of the genetic variations in humans. Some changes in coding regions of DNA tend 
to alter the amino acid sequence and therefore affect the produced protein. The human 
glutathione S-transferase class pi (hGSTP1-1) has been studied for its involvement in a broad 
range of functions such as detoxification. It has recently drawn interest because of its increased 
levels in tumours. In order to incorporate mutations into the hGSTP1-1 DNA sequence, site 
directed mutagenesis was performed to obtain the SNP forms and their effect on the structure, 
stability and function were studied. The activity was measured using the 1-chloro-2,4-
dinitrobenzene (CDNB-GSH) enzyme assay. The SNP forms L159M, located in the 
hydrophobic core of domain 2, and T110S positioned next to the H-site of the protein did not 
affect the secondary structure when compared to the wild-type, while the L159M SNP form 
had an effect on the protein’s tertiary structure when determined using CD and fluorometer. 
Both of the SNP forms showed a difference in the exposure of hydrophobic surfaces as 
indicated by ANS binding studies. The SNPs had no effect on the thermal stability of the 
protein although the enzyme activity of SNP L159M and the SNP T110S is decreased by about 
57% and 18 %, respectively, when compared with the activity of the wild-type.  The SNP 
T110S does not have a significant effect on the structure and activity of hGSTP1-1 while the 
L159M showed significant changes suggesting possible effects on both the structure and 
activity. This may be attributed to its location in a conserved hydrophobic core of domain 2 of 
hGSTP1-1. The decrease in activity of the L159M hGSTP1-1 may have a negative role on the 
detoxification function of the protein. 
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CHAPTER 1: INTRODUCTION 
1.1 Gene mutations in human 
Gene mutations are changes formed permanently in the DNA sequence of the human genome 
causing the sequence to be different from that of other people (Cooper et al., 1998). Different 
types of mutations can occur in a genome and these mutations vary in size such that a single 
base or a region of DNA is changed. There are different types of mutations and these include 
insertions, deletions and substitution mutations (Tian et al., 2008). Insertion mutations occur 
when an extra base pair is incorporated in a gene, while deletion mutations occur when a base 
or a section of DNA is deleted. Substitution mutations are those in which a nucleotide is 
substituted with a different nucleotide (Duret, 2009). They often occur during transcription of 
DNA and the change in a nucleotide may result in an altered amino acid codon, which may 
have an effect on the newly synthesized protein (Tian et al., 2008). This modification in an 
amino acid may produce a protein with an abnormal structure. Occasionally the structure may 
not be altered but its function may be affected.  
Mutations that affect the protein structure or function are called missense mutations while 
those mutations which change the DNA sequence without any functional change in the 
overall protein produced are called silent mutations (Tian et al., 2008). The types of 
mutations mentioned above may be induced or spontaneous. When humans are exposed to 
certain environmental factors such as chemical carcinogens and ultraviolet light the mutations 
resulting from these factors are regarded as induced while those that occur naturally 
constitute spontaneous mutations (Lynch et al., 2008). Spontaneous mutations occur at lower 
frequencies as compared to induced ones and this can be attributed to the chemical instability 
of purine and pyrimidine bases and copying errors during DNA replication, most often 
occurring when there is a foreign chemical or toxin interacting with the DNA. These 
spontaneous mutations may be recognized across human populations. Some of them are 
infrequent while some may occur more frequently in a human population (Housman, 1995). 
When studied in the context of human population, those mutations that occur most frequently 
than one percent in the population are referred to as polymorphisms (Housman, 1995). These 
polymorphisms are very common and because of this reason they are thought to be normal in 
human DNA (Marth et al., 1999). They may be large in size or smaller, meaning that multiple 
or single nucleotides can be altered in a sequence. When only one nucleotide has been 
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mutated and has shown significance across a population, those polymorphisms are called 
single nucleotide polymorphism (SNPs) (Taillon-Miller et al., 1998). 
 
1.2 Single nucleotide polymorphisms (SNPs) and their types 
SNPs are the most frequent type of genetic variations in humans. They account for about 90% 
of sequence variations with an overall frequency of approximately one per 1000 bases 
(Tailon-Miller et al., 1998). SNPs have been identified to be hereditary or acquired. Some 
hereditary SNPs cause phenotypic variations in humans and the traits get inherited within 
generations. On the contrary, acquired SNPs cannot be passed on to the next person and thus 
have no influence on the change in generations of human populations (Cooper et al., 1998). 
SNPs have been classified according to where they occur in the gene. The known types of 
SNPs are non-coding and coding region SNPs. Those on coding regions are made up of 
synonymous and non-synonymous SNPs (Sunyaev et al., 2001). Synonymous SNPs are also 
called silent substitutions because they do not change amino acid sequence and therefore do 
not cause phenotypic variations. Wang and Moult (2001) discovered that on average every 
gene has approximately four SNPs located on coding regions and nearly half of them lead to 
missense mutations in the matching protein while the additional half of these mutations are 
silent. These SNPs typically occur on the exon of a gene coding for a protein (Schork et al., 
2010). Silent mutations modify an amino acid sequence to a different codon but the function 
and structure of the protein remains the same. This is because the genetic code is redundant, 
denoting that some amino acids are coded by more than one codon. Some codons which code 
for a certain amino acid differ by only one base pair from other bases therefore when a 
mutation occurs; the usual base is substituted by another base resulting in the same amino 
acid (Sunyaev et al., 2001). Synonymous mutations therefore do not have a negative effect on 
the codon and overall function of the coded protein. Non-synonymous SNPs, however, may 
result in non-functional proteins or an incorrect structure. 
They alter the amino acid sequence of a protein resulting in biological changes in living 
organisms and they also cause changes in DNA resulting in the change of the structure and 
function of proteins in the biological system. These changes may then be the basis of diseases 
and disorders in humans (Schork et al., 2010). Depending on where the SNP is located in the 
protein, these SNPs may affect the proteins stability, structure and or its function. The 
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number of possible damaging SNPs in a human individual or population is of major concern 
because if the number is high, the welfare of humans can be affected. 
 
1.2.1 Effect of SNPs on DNA coding regions 
Non-synonymous SNPs alter the sequence of the protein resulting in changes of the structure 
which may affect the function of the protein and eventually causing a disease or a disorder. 
Proteins play a very important role in the biological system of humans such as getting rid of 
toxins, viruses and bacteria that are a threat to the body. They play a role in maintaining 
functional harmony of the biological system. Proteins also play distinct roles. The change in 
the protein sequence affects the protein negatively, sometimes mutations can improve the 
function of the protein or it can reduce its activity or abrogate it altogether.  
The biological system of humans is exposed to a large number of toxins daily from food, 
drugs or the air in the atmosphere. This is why proteins responsible for detoxification are 
critical. Cells defend themselves from foreign particles by pumping them out of the system. 
Many cells are involved in the removal of these foreign particles. Some of the proteins 
involved in such functions are drug transporters. Drug transporters are mostly found in cell 
membranes and are responsible for protecting the cell against xenobiotics. The MDRI 
(ABCBI) gene encodes a membrane bound transporter that actively clears a wide range of 
compounds from the cell. Although it is a conserved gene, there is growing evidence that 
polymorphisms found in this gene affect substrate specificity (Gottesman and Pastan., 1993). 
MDRI (P-glycoprotein, ABCBI) became the first ABC-transporter identified. It falls under 
the ATP-binding cassette (ABC) transporter superfamily (Chen et al., 1986). The C3435T 
SNP found in the gene displayed reduced MDRI expression and the C3435T allele was linked 
with two- fold reduction of MDRI expression in the duodenum (Hoffmeyer et al., 2000). 
Enzymes contributing to detoxification play a role in protecting the body against toxins 
initiated by smoke from tobacco, vehicle fumes and dust. Amongst other processes and 
enzymes that act against the destruction of cells by toxins, is one enzyme that has been of 
critical importance. It destroys reactive oxygen species (ROS) and provides the balance 
between the production and removal of ROS. Superoxide dismutase (SOD) has been a very 
important target enzyme for improving the efficiency of the ROS regulation. It constitutes the 
first line of defense against ROS (Alscher et al., 2002). This metalloenzyme catalyses the 
conversion of superoxide radical anion (O2
-
) to two less damaging species which are oxygen 
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(O2) and hydrogen peroxide (H2O2). This mechanism occurs in the first series of defence 
reactions against cytotoxic free radicals which are generated during reduction of molecular 
oxygen (McCord and Fridovich., 1969). H2O2 is also harmful to the cell and thus gets 
hydrolysed to water and oxygen by catalase (Alscher et al., 2002). The formation and 
removal of superoxide is balanced under normal conditions and an increase in O2 
overwhelms the cells resulting in the production of SOD under abnormal conditions (Alscher 
et al., 2002). Most human metabolic reactions occur under aerobic conditions and it is 
important that oxygen is regulated and SOD will be produced anywhere in the cell where 
there are aerobic metabolic reactions taking place maintaining the production of these O2 
molecules. Genotypes of SOD and associations with levels of plasma SOD activity have been 
studied in Caucasian (German), Asian (Japanese) and African (Xhosa) populations.  The 
implications of SOD2 A16V SNP, which is a dimorphism that leads to substitution in the 
mitochondrial targeting sequence was shown to significantly influence SOD plasma activity 
and SOD R231G. The SOD R123G causes substitution in the heparin-binding domain of 
SOD3 influenced total SOD activity (Lida et al., 2008). 
A large number of studies have linked the effects that SNPs have on coding regions and the 
proteins produced from these DNA sequences. Amongst proteins involved in detoxification, 
is glutathione S-transferase (GST) which plays a very important role in prevention of cancers 
by removing toxins in the body before they interact with DNA (Abdall et al., 2002). 
The damage caused by smoking to genes has been shown to cause susceptibility to chronic 
obstructive pulmonary diseases (COPD) (Ishii et al., 1999). Investigation of SNPs on GST 
was performed in subjects with COPD and the amount of Ile105 homozygotes was 
discovered to be considerably higher when compared to subjects without the disease. Up to 
79% of subjects with the disease were found to have acquired the SNP (Ile105). It was then 
concluded that these genetic polymorphisms may have a role in the formation of COPD. The 
dominant Ile105 polymorphism has led to this finding and to a conclusion that the human 
GST class P1-1(hGSTP1-1) Ile105 genotype may have less protective ability against tobacco 
smoke. The A105 SNP is also implicated in early-onset of coronary artery disease. This has 
been reported in young South African Indians (Phulukdaree et al., 2012). Investigation of 
SNPs in GSTs therefore gives better understanding of diseases that may arise in the presence 
of these mutations. 
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1.3 Glutathione S-transferases (GSTs) 
GSTs are enzymes under the same family that play a role in detoxifying potentially harmful 
endogenously derived  reactive compounds in the biological system (Hayes and 
Pulford,1995). They achieve this role by catalysing the conjugation of hydrophobic and 
electrophilic substances that have a reduced glutathione. These proteins are found in living 
organisms such as microbes, plants, fish, birds, insects and mammals and in cell 
compartments such as the nucleus, mitochondria, cytoplasm and endoplasm reticulum (Hayes 
and Pulford, 1995). 
Two distinct super families of GSTs possess transferase activities (Hayes and Strange, 2000). 
The first group of GST enzymes to be characterized was the cytosolic or soluble GSTs 
(Boyland and Chasseeaud, 1969; Mannervik, 1985). The classification of GSTs is based upon 
protein sequence and structure, where amino acid sequence similarity between members of 
the same class is greater than 40 %.   At least sixteen members in this superfamily have been 
found in humans (Board et al., 1997; Hayes and Strange., 2000) and have then been allocated 
to 8 families or classes based on the degree of their sequence identity. These include Alpha, 
Theta, Zeta, Omega, Mu, Pi, Kappa, and Sigma (Mannervik, 1985). All the cytosolic GSTs 
are dimers which are made of two monomers with domains I and II which form lock-and-key 
structures with each other (Wu and Dong, 2012). The dimeric structure of the GSTs has been 
suggested to improve protein stability and it stabilizes the active site for efficient catalysis 
(Armstrong, 2010). 
Four additional classes of this superfamily are found in bacteria, insects and plants (Hayes 
and Strange, 2000). The second superfamily is comprised of microsomal transferases and has 
selected membrane-associated proteins in eicosanoid and glutathione metabolism or MAPEG 
in short (Jakobsson et al., 1999) with at least six members of this superfamily found in 
humans (Jakobsson et al., 1999). Their function is not detoxification, unlike the soluble GST 
enzymes. They are involved in biosynthesis of leukotrienes and prostanoids, and endogenous 
lipid signalling molecules (Jakobsson, 1999). 
Soluble enzymes play very important roles in regulating the toxic substances that invade the 
body. The human GST class pi has been studied for their involvement in a broad range of 
functions and it has attracted particular interest because of its increased levels in cancer cells 
(Abdall et al., 2002).  
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1.3.1 Functions of hGSTP1-1 
The hGSTP1-1 falls under the cytosolic superfamily and like other GSTs it removes toxic 
molecules from the body by conjugating electrophilic molecules to the GSH tripeptide 
resulting in these toxins being less toxic and expelled easily from the body (Armstrong, 
1991). It plays a role in regulating the proportion of toxins in the body, especially those 
which have been associated with neurodegenerative diseases (Brambilla et al., 2010). The 
human GSTP1-1, being a soluble enzyme catalysis the detoxification of electrophilic diol 
epoxides. These epoxides are produced by the metabolism of polycyclic aromatic 
hydrocarbons (Adler et al., 1999). GSTP1-1  in  human  is  not  only  responsible  for  
detoxification  but  also  has  many  other functions in the cell. Firstly, they can function as 
molecular carriers of hydrophobic ligands, which are enzymes that enable intracellular 
transport of non-substrate substances in cells (Listowsky, 1993).  The human GSTP1-1 
moves between cell compartments such as endoplasm reticulum and cytoplasm carrying 
ligands (Sheratt et al., 1998). It has also been implicated in protein binding and binding of 
compounds containing iron and nitric oxide (Vasieva, 2011). 
Secondly, soluble hGSTP1-1 has been shown to bind other proteins modulating their 
function. This is observed when hGSTP1-1 interacts with c-Jun kinase (Adler et al., 1999). It 
inhibits c-Jun N-terminal kinase (JNK) via a direct protein-protein interaction. JNK is a 
mitogen-activated protein kinase that is involved in apoptosis, cellular differentiation and 
proliferation. It is activated in the presence of protein synthesis inhibitors, ultraviolet 
radiation and other stress stimuli, JNK in turn phosphorylates c-Jun, a component of the 
activator protein-1 (AP-1) transcription factor leading to induction of AP-1-dependent target 
genes which are involved in cell proliferation and cell death (Laborde, 2010). hGSTP1-1 
therefore is an inhibitor of signalling pathways leading to apoptosis. They are also involved 
in functions such as sequestering of carcinogens and modulating signal transduction 
pathways (Listowsky, 1993; Adler et al., 1999 and Cho, 2001). 
Thirdly, hGSTP1-1 has been shown to activate peroxidase function in peroxiredoxin V1 
(Prdx6).  Heterodimerisation  of  prdx6  with  hGSTP1-1  that  is  loaded  with  glutathione 
regulates  the  glutathione  peroxidase  activity (Manevich et al., 2002).  Prdx6 is a very 
important antioxidant enzyme that plays a role in protecting biological membranes against 
damage caused by liquid peroxidation (Manevich et al., 2002). The combination of amino 
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acids found in the active site of hGSTP1-1 allows it to bind a variety of ligands and 
substrates. These functions are strongly influenced by the structure of this protein. 
 
1.3.2 Structure of GSTP1-1 
The  structure  of  hGSTP1-1  allows  it  to  perform  many  functions  as  mentioned  above. 
The human GSTP1-1 is homodimeric and composed of two subunits made of 207 residues 
each. These subunits are folded into two domains that display different structures (Reinemer 
et al., 1992). The first domain (domain 1: residues 1-74) forms a thioredoxin-like fold while 
domain 2 (residues 81-207) is exclusively alpha helical, containing five alpha helices (Figure. 
1) (Armstrong, 1991). 
 
Figure 1.1 A diagram illustrating the homodimeric quaternary structure of hGSTP1-1.  
The two subunits each comprising of two domains is shown with the dimer interface. Domain 
1 shows the theoredoxin-like fold (red) and domain 2 shows the alpha helical fold (green). 
The image was generated using Pymol coordinates PDB 2A2R. 
The hGSTP1-1 subunits are 25 kDa in size with active sites suggested to function 
independently of the other (Stenberg et al., 2000). Each of these dimers have an active site 
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suggested to contain a glutathione binding site named the G-site and the hydrophobic binding 
site called the H-site (Mannervik, 1985; Dirr et al., 1994). The hydrophobic amino acid 
combination in the H-site of the hGSTP1-1 strongly influences the substrates that bind to it 
(Armstrong, 1997). The location of the binding site for the hydrophobic substrates (H-site) 
was first discovered by Reinemer and his group in (1992) from the crystal structure of the 
human GST class pi which was co-crystallized with S-hexyl glutathione. The H-site is 
adjacent to the G-site and it is formed within a cleft between the N- and the C-terminal 
domains. 
Figure 2 shows where the G-sites and H-sites are located in the structure of hGSTP1-1, the S-
hexyl moiety of the S-hexylglutathione binds the H-site of the protein while the glutathione 
binds to the G-site (Hegazy et al., 2008). 
 
  
Figure 1.2 Structure of hGSTP1-1 showing the active site in complex with S-
hexylglutathione. The active site of the hGSTP1-1 enzyme binds S-hexylglutathione with 
glutathione binding at the G- site and S-hexyl moiety of S-hexylglutathione binding at the H-
site. The image was generated from PyMol using the coordinates for PDB 1GSS. 
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The H-site is located at the domain interface and made up of structural components from both 
domain 1 and 2 (Dirr et al., 1994).  It is made up of three regions, the loop between the first 
β-strand and the first α-helix, the fourth α-helix and the C-terminal tail (Wu and Dong, 2012). 
It binds a much broader range of substrates whereas the G- site is highly specific for GSH. 
The H-site binds inhibitors such as ethacrynic acid (Oakley et al., 1997). Even though some 
substrates can share the H- and the G-site, the ethacrynic acid is bound entirely in the H-site, 
although in a manner not conducive for conjugation with GSH. The GSH and the ethacrynic 
acid both interact with catalytic residues in the active site by forming conjugations with the 
tyrosine in position 108. The hydrogen bonds form between the ketone moiety of the 
ethacrynic acid stabilising the Michael addition reaction (Lo Bello et al., 1997). A water 
molecule forms hydrogen bonds between Tyr7 and the sulfur atom of the GSH and the 
second water molecule forms a bond with the Tyr108. The hydrogen bond interaction 
between the GSH and the catalytic residues play a crucial role in hGSTP1-1 catalysis by 
stabilising the activated GSH (i.e. the GS
- 
thiolate) (Armstrong, 2010). 
The hGSTP1-1 has SNPs identified in its sequence and certain SNPs have been found to be 
dominant in patients with diseases such as COPD. How these SNPs cause diseases is still to 
be investigated. 
 
1.3.3 Effect of SNPs on hGSTP1-1 
SNPs  can  affect  both  the structure  and  function  of hGSTP1-1  leading  to  disorders and 
diseases in human. There are diseases that are thought to be caused by SNPs in DNA level, 
affecting the production of a protein (Tian et al., 2008). The human GSTP1-1 causes 
susceptibility to triple-negative breast cancer cell metabolism and pathogenicity (Louie et al., 
2016) and SNPs in the protein also influence cause of diseases. SNPs found in DNA coding 
for hGSTP1-1 were found to change the detoxification process leading to elevated 
accumulation of carcinogenic metabolites and therefore increasing the risk of breast cancer 
sensitivity in women (Masoodi et al., 2012, Onay et al., 2006).  The protein is also affected 
by SNPs, for example subjects with chronic obstructive pulmonary diseases (COPD) were 
found to have high levels of the Ile105 SNP as compared to subjects without the disease (Ishii 
et al., 1999). 
Table 1.1 shows certain single nucleotide polymorphism found in hGSTP1-1 and their effects 
on protein functions and health of humans. 
  10 
 
Table 1.1 SNPs found in hGSTP1-1 and their implicated diseases 
GSTP1-1 polymorphisms Effect of SNPs on human 
health 
References 
E32V Occurs more than 1 % in 
Mexican Americans 
Moyer et al., 2008 
D58N Effect on humans has not 
been determined 
Moyer et al., 2008 
I105V More significant in asthmatic 
patients and causes 
susceptibility to asthma 
Karam et al., 2012 
Hanene et al., 2006 
Lower enzyme activity and 
causes less effective 
detoxification and more 
susceptibility to neoplasms 
Vasieva, 2011 
Occurs more than 10 % in 
African Americans, 
Caucasians Americans and 
Han American Chinese 
Moyer et al., 2008 
Higher among diabetic 
patients and diabetic patients 
without vascular 
complications 
Zaki et al., 2013 
Deletion of Ile105 Was found to abolish enzyme 
activity and increase 
susceptibility to oxidative 
stress 
Hanene et al., 2006 
A114V Increases the risk of 
developing oesophageal 
squamous cell carcinoma.  
Associated with tobacco 
smokers 
Li et al., 2010 
D147Y Not determined Moyer et al., 2008 
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F151L Substitution of F151L near a 
conserved folding module 
has been found to lower 
stability of GSTP1-1 
Lin et al., 2003 
S185S Not determined Lin et al., 2003 
R187W Not determined Moyer et al., 2008 
 
1.4 Human GSTP1-1 and its relation to cancer 
SNPs in hGTSP1-1 have been linked to several diseases as mentioned above, mostly cancers 
because SNPs alter the DNA sequence. There are many different cancers that have been 
implicated in hGSTP1-1, such as cancers of the bladder and testicles (Harries et al., 1997) 
and lung cancer (Ryberg et al., 1997). A large number of human tumours such as colon 
cancers, pancreas, uterine cervix, stomach and breast cancer have shown a raised expression 
of hGSTP1-1 enzyme (Coles and Ketter, 1990, Tsuchida and Sato, 1992). Human GSTP1-1 
methylation and expression has been reported in prostate cancer (Martignano et al., 2016). 
The hGSTP1-1 not only has been shown to increase in patients with certain SNPs but its 
expression in tumour cells is correlated with resistance of these tumours to anti-cancer drugs 
(Laborde, 2010). This demonstrates that the protein defends these tumours from being 
destroyed by chemotherapeutics such as chlorambucil, cyclophosphamide, cisplatin and 
N,N’-bis (2-chloroethyl)-N-nitrosourea (BCNU).  It achieves this by direct detoxification of 
the drugs and by blocking apoptosis of the cancer cells by interacting with c-JNK kinase. It is 
therefore necessary to find specific inhibitors of the hGSTP1-1. γ-glutamyl-(S-benzyl) 
cysteinyl-D-phenylglycine (TLK117) and has been reported to be the most selective 
hGSTP1-1 inhibitor (Lyttle et al., 1994). It has a Ki of 0.4 µM for hGSTP1-1 as compared 
other classes such as Alpha and Mu (Koehler et al., 1997). The basis for the difference in the 
Ki values for these classes can be attributed to the D-phenylglycine moiety of this inhibitor 
which forms contacts with the hydrophobic residues while maintaining the multiple 
hydrogen-bond interactions that occur between the GSH and the G-site in hGSTP1-1. The 
binding of the inhibitor to either the Mu or Alpha class, however, causes steric clashes with 
the C-terminal tail because of the substituted glycyl moiety in GSH by the D-phenylglycine 
group (Oakley et al., 1997). When the inhibitor is bound to the Alpha class, the bulky 
modification would have a steric clash with the Phe220 and Phe222 residues (Sinning et al., 
1993) whilst in the case of Mu class the clash would come from interactions with Trp7, 
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Met43 and Arg42 residues (Ji et al., 1992). A specific inhibitor for the hGSTP1-1 would be 
of great importance for the cancer patients and those cancers associated with specific SNPs. 
Several GSTP1-1 inhibitors have been reported lately. The tyrosine-reactive irreversible 
inhibitor has also been shown to inhibit the protein (Crawford and Weerapana, 2016). It 
contains a dichlorotriazine that irreversibly inhibits hGSTP1-1. It is selective for GSTP1-1 
within cellular proteomes and the Y108 residue in the protein allows for the inhibitor to bind 
(Craford and Weerapana, 2014). An anti-cancer compound called piperlongumine (PL) also 
shows inhibition of GSTP1-1 (Harshbarger et al., 2017). The discovery of all these inhibitors 
will also improve cancer therapy against cancers caused by SNPs across populations. 
 
1.5 Population distribution of human diseases associated with SNPs found in hGSTP1-1 
The dominance of a certain SNP in humans can be influenced by the environment they are in, 
their lifestyles and mostly by genetic heredity. This is also the reason why some diseases 
affect many people in some areas than others.  Cases that show prevalence of diseases in 
certain areas when compared to others have been documented. For example, in South Africa 
the hGSTP1-1 SNP substitution, A114V amino acid change has been found to cause an 
increase in the risk of developing oesophageal squamous cell carcinoma and tobacco smokers 
are more vulnerable (Li et al., 2010). Additionally, a study done by Phulukdaree and his 
group (2012) in the same country showed higher frequencies of hGSTP1-1 Ala105 in patients 
with coronary artery diseases. 
SNPs such as the hGSTP1 I105V polymorphism has been associated with susceptibility to 
asthma in Egyptians (Karam et al., 2012). The I105V SNP is very dominant and has been 
implicated in many diseases in different countries. A study done by Moyer and his group 
(2008), had further shown that the I105V occurs greater than 10 % of the time in African 
Americans, Caucasian Americans, Han American Chinese and Mexican Americans, while the 
E32V occurs less than one in Mexican Americans. SNPs are responsible for a number of 
diseases and there may be more diseases that have not been discovered yet that are caused by 
them. SNPs can also have a positive effect on the function of the protein by either improving 
its function or having a stabilising effect on the protein. 
Furthermore, Manevich and his group in 2012 did a study from in silico modelling of 
hGSTP1-1 peroxiredoxin (Prdx6) heterodimer, they have shown that the Ile105 and Ala114 
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polymorphic sites of hGSTP1-1 are in close proximity to the binding interface, and thus these 
polymorphic variants may have a role in regulating the function of Prdx6 which may further 
influence human population susceptibility to oxidative stress. Their effect on the structure 
and function of the affected protein is likely to contribute towards these disorders. It is 
therefore very important to study these effects on proteins such as hGSTP1-1. SNPs which 
have been identified in hGSTP1-1 for this study are displayed in Figure 1.3 below. 
 
Figure 1.3 Structure of hGSTP1 showing positions of identified SNPs. The positions of 
amino acids Thr110 (yellow) and Leu159 (magenta) are shown in the diagram above. The 
T110S is located closely to the H-site (red circle) of the hGSTP1-1 and the L159M is located 
in the hydrophobic core of domain 2 of hGSTP1-1 in α-helix 6. 
In this study, effects caused by SNPs in the human GSTP1-1 are investigated. An SNP in its 
hydrophobic core and one that is located closest to the H-site of the protein are studied. The 
hydrophobic core is suspected to play a critical role in the folding process of this protein and 
contributes to the interaction between the GSH on its active site (Luca et al., 2014, Dirr et al., 
2005, Cocco et al., 2001, Dragani et al., 1997). T110S SNP is located in the H-site of the 
protein and close to a catalytic residue Tyr109. Therefore this study focuses mainly on how 
the structure and function of this protein is affected by these SNPs. 
 
Thr110 
Thr110 
Leu159 
Leu159 
H-site 
H-site 
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1.6 AIM AND OBJECTIVES 
1.6.1 Aim 
This study is aimed at investigating the effects that naturally occurring single nucleotide 
polymorphisms found in the hGSTP1-1 have on its structure, stability and function. 
1.6.2 Objectives 
1.6.2.1 Design reverse and forward DNA primers for site-directed mutagenesis to generate 
the SNP forms of the wild-type hGSTP1-1. 
1.6.2.2 Sequence the SNP forms in the DNA sequence to confirm the presence of codon 
changes for each SNP. 
1.6.2.3 Express and purify the wild-type and SNP hGSTP1-1 proteins. 
1.6.2.4 Determine the structural properties of the mutated protein and compare them to those 
of the wild-type hGSTP1-1. 
1.6.2.5 Perform CDNB-GSH assay and ANS binding studies to determine enzymatic 
functions of the SNP forms and compare them to those of the wild-type hGSTP1-1 protein.  
1.6.2.6 Perform computational docking studies to determine the binding sites of the ANS as a 
hGSTP1-1 ligand.  
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CHAPTER 2: MATERIALS AND METHODS 
2.1 Materials and Methods 
The N-terminal His 6-tagged human GSTP1-1 sequence which was used for this study was a 
gift from S. Y. Blond (Centre for Pharmaceutical Biotechnology, University of Illinois, 
Chicago, IL). The hGSTP1-1 sequence was cloned into pET-15b vector, and the presence of 
the hGSTP1-1 sequence in the pET-15b vector was confirmed by cloning the vector into XL10 
Gold
®
 ultra-competent (Stratagene, La Jolla, CA, USA) cells and grown to produce more DNA 
which was extracted using GeneJET™ Plasmid Miniprep Kit (Fermentas, Ontario, Canada) 
and sent for sequencing at Inqaba Biotech (Pretoria, South Africa). The SNP forms were 
designed by PCR and identity of all the plasmids was confirmed by sequencing at Inqaba 
Biotech. The hGSTP1-1 wild-type and SNP forms were expressed using T7 Express Iq E. coli 
competent cells to obtain protein and were purified using the ÄKTA FPLC (fast protein liquid 
chromatography). The purified wild-type and SNP form were used for functional and structural 
characterisation. The reagents used were of analytical grade and all solutions were prepared 
using distilled water and filtered through a 0.45 µm pore size filter. Materials needed at high 
purity and grades are listed in Table 2.1.  
Table 2.1 Materials used at high purity and grade 
Material Source Location 
Primers for mutagenesis  Inqaba Biotec Pretoria, South Africa 
Quikchange® Lightening Mutagenesis Kit Stratagene La Jolla, CA, USA 
GeneJET™ Plasmid Miniprep Kit Fermentas Ontario, Canada 
SDS-PAGE molecular mass markers Fermentas Ontario, Canada 
DNA Ladders Fermentas Ontario, Canada 
Isopropyl β-D-thiogalactopyranoside (IPTG)  Sigma-Aldrich St. Louis, MO, USA 
Coomassie Brilliant Blue G-250  Sigma-Aldrich St. Louis, MO, USA 
Dithiothreitol (DTT)  Melford Laboratories 
Ltd. 
Suffolk, UK 
5 ml Histrap purification column GE Healthcare  Buckinghamshire, UK 
Gel filtration standards Bio-Rad Johannesburg, South 
Africa 
T7 Express Competent Cells New England Biolabs Ipswich, MA, USA 
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Hi Load™ 16/600 Superdex™ 75 pg GE Healthcare Buckinghamshire, UK 
Ultracel® 10 kDa Ultrafiltration Discs Amicon Bioseparations Jeffery, NH USA 
8 Anilino-1-naphthalenesulfonic acid (ANS) Sigma-Aldrich St. Louise, MO, USA 
Reduced L-glutathione (GSH) Sigma-Aldrich St. Louis, MO, USA 
1-Chloro-2,4-dinitrobenzene (CDNB) Sigma-Aldrich St. Louis, MO, USA 
XL10 Gold
®
 ultra-competent Stratagene La Jolla, CA, USA 
 
2.2 Experimental procedures 
To obtain the plasmid containing the hGSTP1-1 sequence, the human GSTP1-1 sequence was 
cloned into pET-15b vector which was used to transform XL10 Gold ultra-competent E. coli 
(Stratagene) cells. The hGSTP1-1 DNA was synthesized by growing the cells and extracting 
the DNA which was used to make the SNP proteins using PCR. The wild-type hGSTP1-1 and 
the SNP DNA were used to transform T7 E. coli cells which were used for expression of the 
proteins. The purified protein was then used to characterize the structural and functional 
properties of the wild-type protein while comparing them to those of the L159M and T110S 
SNP forms. The detailed methods of the experiments performed are described below.  
2.3 Identification and construction of hGSTP1-1 SNPs  
SNPs common in hGSTP1-1 were identified on the dbSNP data base 
(http://www.ncbi.nlm.nih.gov/projects/SNP) and an SNP located in the hydrophobic region of 
the hGSTP1-1 (L159M) and the one closest to the H-site (T110S) were selected. These were 
chosen to investigate how SNPs in the hydrophobic core of hGSTP1-1 affects its structure and 
possibly affect its function, primarily because the hydrophobic core of hGSTP1-1 has been 
found to have a role in the folding and stability of the protein (Luca et al., 2014, Dirr et al., 
2005, Cocco et al., 2001, Dragani et al., 1997).  SNPs closest to the hGSTP1-1 H-site catalytic 
residue Tyr109 which plays a role in stabilising the binding of substrates to the active site 
(Prade et al., 1997) also raise questions as to whether they affect the binding of substrates and 
ligands to the protein and also possibly affect its function. T110S SNP, located close to the 
Tyr109 catalytic residue was selected to investigate its effect on the protein. These SNPs have 
high frequencies and have been validated by either cluster, frequency or hapmap 
(http://www/ncbi.nlm.nih.gov/snp). The accession numbers for the L159M and T110S SNPs 
are rs4986948 and rs199567349, respectively. Primers used for the construction of these SNPs 
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were designed using the QuikChange primer designer by Agilent Technologies: 
(http://www.genomic.agilent.com/primerDesignProgram.jsp?&_requestid=103276).  
The reverse and forward primer sequences (Table 2.1) were synthesized at Inqaba Biotech. 
Table 2.2 Forward and reverse primers used for mutagenesis 
Name Sequence (5'-3') 
T110S-f 5'-cccgcctcatagttgctgtagatgagggaga-3' 
T110S-r 5'-tctccctcatctacagcaactatgaggcggg-3' 
L159M-f 5’-tcatggatcagcagcatgtccagcaggttgtag-3’ 
L159M-r 5’-ctacaacctgctggacatgctgctgatccatga-3’ 
 
These primers were used for mutagenesis using a Bio-Rad MyCycler thermal cycler machine 
and a Quick Change Lightning Site-Directed Mutagenesis kit from Agilent technologies. The 
experiment was performed as described by Zheng et al., (2004). To ascertain that only the 
desired mutations had occurred during the experiments, the open reading frame of the plasmid 
encoding hGSTP1-1 wild-type and each SNP form DNA was sequenced at Inqaba Biotech. 
The pET-15b plasmid is 5.7 kb in size and it has an AmpR gene which allows the E. coli to be 
resistant to ampicillin which further allows selection of only cells containing the plasmid. 
2.4 Expression of hGSTP1-1 wild-type and SNP forms 
The vectors containing the cDNA hGSTP1-1 sequences and those containing the L159M and 
T110S SNPs were used to transform 50 µl XLGold® Ultra-competent E. coli cells and the T7 
Express Iq competent cells. The cells were transformed using an updated transformation 
method adapted from (Froger and Hall, 2007). The 50 µl competent cells were left to thaw on 
ice for 15 minutes before adding 2 µl of 90 ng/µl plasmid DNA. The solution was gently 
mixed before heat shocking the cells for 10 seconds at 42 ºC in a heating block to disrupt the 
bacterial cell wall so it can take up DNA and the cells were immediately placed on ice for 5 
minutes to repair their cell walls from injury caused by heat shock. The competent cells were 
then added to 950 µl SOC media (2 % (w/v) tryptone, 0.5 % (w/v) yeast extract, 2.5 mM KCl, 
10 mM glucose, 20 mM MgCl2, 20 ºC) and then grown in an incubator for an hour at 37 ºC 
while agitating at 250 rpm. The transformed E. coli cells were then plated on agar plates (2.3 
% (w/v) plate count agar) (Merck) containing 50 µg/ml carbenicillin and left to grow overnight 
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(~16 hours). Single colonies were picked from each of the wild-type, L159M, T110S SNP 
plates and used to perform the expression of hGSTP1-1 protein. 
The expression of hGSTP1-1 wild-type protein, L159M and T110S SNP forms was done using 
E. coli T7 cells. The E. coli T7 cells containing the vector pET-15b which has the hGSTP1-1 
sequence were grown overnight in 2YT media (1.6 % (w/v) tryptone, 1.0 % (w/v) yeast extract 
and 0.5 % (w/v) NaCl). The 98 ml of media in 500 ml were inoculated in 2 ml overnight 
culture making 1:50 dilutions and 50 µg/ml of carbenicillin was added. The culture was grown 
in an incubator operated at 230 rpm at 37 ºC until mid-log growth phase (OD600 = 0.6) at which 
point 0.2 mM IPTG was added to induce expression. The cells were then allowed to express 
the proteins for 6 hours and the cells were harvested by centrifugation for 20 minutes at 4000 x 
g in Sorvall Lynx 4000 centrifuge (Thermo scientific) and re-suspended in buffer (50 mM tris-
HCl, 0.5 M NaCl, 0.02 % (w/v) sodium azide, 50 mM imidazole) at pH 8. The two hGSTP1-1 
SNP forms were induced with 0.2 mM IPTG at a starting temperature of 30 ºC and then 0.2 
mM IPTG was added every 2 hours. The temperatures were also reduced by 2º C every 2 
hours. After 6 hours of incubation the cells were harvested and stored in the –80 ºC freezer 
until use for purification. 
 
2.5 Purification of hGSTP1-1 wild-type and SNP forms 
The cells were removed from the freezer and thawed in ice. In 50 ml of the cell culture, 10 
µg/ml DNAse was added, with 10 mM MgCl2 and 1 mg/ml lysozyme to lyse the cells, remove 
DNA and solubilise the protein. The solution was incubated at 30 °C for 30 minutes in the 
incubator. Afterwards, the cells were disrupted by sonication using the XL2000 Series 
Misomix ultrasonic liquid processor (Lasec). The soluble fraction was obtained by subsequent 
centrifugation at 9000 x g for 30 minutes using the Heraeus Megafuge 16 centrifuge (Thermo 
scientific). The supernatant was filter sterilized using 0.2 µm filters. The supernatant was 
loaded onto a 5 ml HisTrap purification column (GE Healthcare), pre-equilibrated with 
equilibration buffer (50 mM Tris-HCl, pH 8, 50 mM imidazole, 0.5 M NaCl and 0.02 % (w/v) 
sodium azide) and purified with the ÄKTA FPLC (fast protein liquid chromatography) 
purification system (GE Healthcare). The His-tagged hGSTP1-1 protein binds to the positively 
charged nickel forming a metal complex between the immobilized transition metal ion bound 
to the resin and imidazole group of histidine. The low concentrations of imidazole in the 
equilibration buffer remove weakly bound proteins from the column. The 6-histidine amino 
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acids allow for binding of the hGSTP1-1 protein to the nickel column. The protein was eluted 
with elution buffer (50 mM Tris-HCl, 0.5 M NaCl, 0.02 % (w/v) sodium azide, 300 mM 
imidazole).  The high concentration of imidazole in the elution buffer out-competes the tagged 
protein for a binding space to the nickel ions in the His-Trap column, thus eluting the protein. 
The fractions collected were run on SDS/PAGE gels and then dialysed in storage buffer (20 
mM sodium phosphate, 0.15 mM NaCl, 1 mM EDTA, 2 mM DTT and 0.02 % (w/v) sodium 
azide, pH 7.4) overnight at 4 ºC then samples were  stored in -20 ºC.  
The presence of the protein in all purification experiments was determined by measuring the 
absorbance of the eluent at 280 nm in real time, using the inbuilt spectrophotometer of the 
AKTA prime automated chromatographic system which is coupled to the computer with 
PrimeView 1.0 software (GE Healthcare Life Sciences, Uppsala, Sweden). 
 
2.6 Protein concentration determination 
The concentration of the hGSTP1-1 wild-type and the two SNP forms (L159M and T110S) 
were measured using a Jasco FP-6300 UV/VIS absorbance spectrophotometer and calculated 
using the Beer-Lambert law: 
A = ελ CL 
where A is the absorbance at 280 nm, ελ is the molar extinction coefficient (M-1 cm-1) at the 
specific wavelength. And C is the molar concentration with l being the path length (cm). The 
maximum absorbance for each of the protein samples, wild-type and SNP forms was used to 
calculate the concentration using the formula above. Substitution of the corrected absorbance 
for the wild-type, L159M and T110S absorbance spectra, the extinction coefficient, and the 
path length (1 cm) into the Beer Lambert law (see above) yields the molar concentration (M) 
of soluble protein. 
The absorbance at 280 nm was also measured for 6 fold serial dilutions of the wild-type, 
L159M and T110S SNP forms and the concentrations were determined by fitting a linear 
regression on the graph. All the absorbance readings were buffer corrected by subtracting the 
blank from the sample. 
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2.7 Sodium dodecyl sulfate –polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE is a detergent with an anionic charge; it binds to proteins and denatures them into 
individual polypeptide molecules (Pitt-Rivers and Impiombato, 1968). It separates proteins 
according to size allowing visualisation of different proteins in a sample upon staining with a 
dye such as coomasie blue, their solubility and most importantly their purity (Laemmli, 1970). 
A soluble protein will be in the supernatant while insoluble protein will remain in the pellet. 
When run on acrylamide gels, the movement of the denatured proteins is based upon charged 
particles in an electric field by electrophoresis. Proteins are separated solely by charge due to 
the sieving effect of the pores of the acrylamide and bis-acrylamide (Summers, 1965). The 
SDS-PAGE gel electrophoresis method consists of two different levels of gels with different 
pHs and different acrylamide percentages, which is the stacking gel and separating gel. The 
stacking gel stacks up proteins before being separated by the separating gel and this provides 
enhancement to the separation of the proteins. The fractions collected after purification were 
run on SDS-PAGE at 100 V. The stacking gel consisted of (4 % (w/v) acrylamide, 0.36 % 
(w/v) bis-acrylamide, 0.05 M Tris-HCl pH 6.8, 0.1 % (w/v) SDS, 0.005 % (w/v) ammonium 
persulfate and 0.2 % (v/v) TEMED) and 16 % acrylamide separating gel.  Samples were 
diluted in a 1:1 ratio with reducing buffer (25 mM Tris-HCl pH 6.8, 4 % (w/v) SDS, 20 % 
(v/v) glycerol, 10 % (v/v) β-mercaptoethanol and 3.5 µg/mL Coomasie Blue R250) before 
loading. The gels were then stained with Coomassie Blue R250 staining solution containing 
(0.1 % (w/v) coomasie dye in 1: 5: 4(v/v/v) acetic acid: methanol: water) and de-stained with 
(1: 4 (v/v) glacial acetic acid: methanol) until the background was clear. 
 
2.8 Structural characterisation of hGSTP1-1 wild-type and SNP forms 
2.8.1 Secondary structure characterization by far-UV circular dichroism (CD) 
CD was used to carry out analysis of the secondary structure of hGSTP1-1. The phenomenon  
determines  whether  a  protein  is  folded  and  therefore  characterises  its  secondary 
structure. It establishes the secondary structure in the far UV spectral region (190-250 nm) 
where the chromophore in this wavelength is the peptide bond and the signal results when it is 
in a systematic folded nature (Greenfield, 2006). It measures differences in the absorption of 
left-handed polarized light from that of right-polarized light resulting from structural 
asymmetry. The CD spectra were obtained on a Jasco J-710 spectrophotometer. The bandwidth 
was set at 1.00 nm and a scan speed of 200 nm/min was used. All protein samples were 
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analysed in 5 mM sodium phosphate buffer at pH 7.4 at 20 ºC. Data were converted to [θ] mrw 
as described by Schmidt (1989).  
 
2.8.2 Tertiary structure characterization by fluorescence spectroscopy 
Fluorescence is an effect of a process with three stages. An appropriate biological specimen 
must possess a fluorescent probe called fluorophore within a specific region within it. Upon 
excitation by a photon of energy such as an incandescent lamp or laser, the fluorophore 
absorbs the photon of energy. This is the first stage of fluorescence called the excitation stage. 
Then the excited stage exists for a short period of time (1-10 nanoseconds) while a fluorophore 
undergoes conformation changes and also forms interaction with its molecular environment. 
Then in the emission stage the fluorophore emits the photon of energy (Gordon et al., 1994). 
There are three known amino acids with intrinsic fluorescent properties; tyrosine, 
phenylalanine and tryptophan. In the native state of most proteins tyrosine emission tends to be 
quenched to nearby tryptophan residues as a result of fluorescence resonance energy transfer 
(FRET). Phenylalanine is not usually used for studies because of lower quantum yields 
(Lakowicz, 1999). Tryptophan, therefore contributes the biggest fluorescence signal in 
proteins. Tryptophan fluorescence was used as a probe for the comparison of the tertiary 
structure of wild-type hGSTP1-1 and the two SNP forms. Tryptophan residues are very useful 
for analysing the nature of the protein; this is because the fluorescence of the indole ring side 
chain residue is sensitive to their micro-environment (Lakowicz, 1999). Furthermore, the 
location of the tryptophan residues affects the fluorescence and therefore can provide for local 
and global conformational changes of a protein. All fluorescence measurements were made at 
20 ºC in a Jasco FP-6300 spec. The excitation band and emission band passes were both set at 
5 mM. Fluorescence measurements were made in 5 mM sodium phosphate buffer at pH 7.4. 
The excitation of tryptophan residues was measured at 295 nm. 
 
2.8.3 Size-exclusion chromatography 
The quaternary structure of the hGSTP1-1 wild-type and SNP forms were examined using size 
exclusion chromatography. This technique separates proteins based on their molecular size 
(Hagnauer, 1982) and is achieved by differentiation exclusion from the pores of the resin in the 
column while passing through it. The column is comprised of stationery and a mobile phase. 
The stationery phase contains porous gel beads which only allow molecules of different sizes 
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to pass through. The mobile phase consists of a buffer or solvent that maintains favourable 
conditions for the molecules being analysed (Preneta, 1993). Larger molecules are eluted from 
the column at the early stages of the experiment because of their limited interaction with the 
stationery phase while the smaller molecules remain in the column longer (Potschka, 1987). 
Gel filtration is an excellent tool for separating monomer, oligomer or aggregated forms of a 
target protein. The Hi Load™ 16/600 Superdex™ 75 pg column was used with KTA protein 
purification system, the column was equilibrated overnight at 20 ºC with equilibration buffer 
(20 mM sodium phosphate, 1 mM EDTA and 0.02 % (w/v) sodium azide). The proteins were 
concentrated with Ultracel
®
 10 kDa Ultrafiltration Discs. Before loading the samples, the 2 ml 
superloop was washed with 10 ml volumes of equilibration buffer and 1 ml 60 µl protein 
samples and 500 µl Bio-rad gel filtration standards consisting of thyroglobulin (from bovine; 
670 kDa), γ-globulin (from bovine; 158 kDa), ovalbumin (from chicken; 44 kDa) and 
myoglobin (from horse; 17 kDa) were loaded and run for 2 hours separately. The AKTA was 
run at 1 ml/min flow-rate and 0.3 MPa pressure limit. The protein eluents were collected and 
run on SDS-PAGE. 
2.9 Stability studies  
The stability of the wild-type and the SNP forms was assessed using CD by varying 
temperatures to determine the heat in which the proteins are least stable leading to unfolding. 
The far UV spectra to determine the secondary structure of the proteins was measured to 
confirm the folded state of the proteins before thermal melting. The hGSTP1-1 has high α-
helical content with peaks at 222, 208 and 193 nm. The wavelength at 222 was used because 
data at higher wavelengths usually have lower absorption and higher signal to noise 
(Greenfield, 2006). The temperatures were set to vary from 0 – 80 ºC and to determine whether 
the proteins unfolding were irreversible the reverse scan was set from 80 – 0 ºC. The protein 
samples were prepared in 5 mM sodium phosphate buffer at pH 7.4. Data were converted to [θ] 
mrw as described by Schmid (1989).  
 
 2.10 Functional characterisation of hGSTP1-1 wild-type and SNP forms 
              2.10.1 GST/CDNB activity assay  
GST activity was assayed spectrophotometrically at 20 ºC using a Jasco FP-6300 absorbance 
spectrophotometer with a 10 mm UV quartz micro cuvette to measure the rate of conjugation 
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of GSH to CDNB. Final substrate concentrations were 1 mM glutathione (GSH), 1 mM 
Chloro-2,4-dinitrobenzene (CDNB) in ethanol and 100 mM sodium phosphate buffer 
containing 1 mM EDTA and 0.02 % (w/v) sodium azide at pH 6.5. The initial protein 
concentration was 152 nM and final concentrations in a test tube were varied from 1 to 10 nM. 
Substrates were added into the 100 mM sodium phosphate buffer pH 6.5 in the order GSH, 
enzyme then CDNB. The mixture was quickly mixed and measured at 340 nm for 60 seconds. 
The GST activity was calculated in µmol CDNB conjugated/min using the published 
extinction co-efficient 9.6 mM
-1
 cm
-1
. Specific activity was calculated by correcting for protein 
content and the specific activity was expressed in µmol/min/mg. 
 
2.10.2 8-Anilinonaphthalene-1-sulfonic acid (ANS) binding 
ANS is an amphipathic anionic dye which can be used as a probe for the detection of nonpolar 
surface on proteins (Abdalla et al., 2002). The fluorescence properties of this molecule are 
largely influenced by the polarity of its surrounding environment. The fluorescence emission 
maximum of ANS shifts to a lower wavelength when bound to the hydrophobic surface, and 
this bathochromic shift is accompanied by an increase in fluorescence intensity (Slavik, 1982). 
A 16 mM ANS stock solution was prepared in 20 mM sodium Phosphate buffer, with 1 mM 
EDTA and 0.02 % sodium azide, at pH 7.4. The concentration of ANS was confirmed using 
the Beer-Lambert law by recording the absorbance at 350 nm and using an extinction 
coefficient of 5000 M-1.cm-1 (Weber and Young, 1964). The ANS fluorescence spectra, in the 
absence and presence of 2 µM GSTP1-1 were recorded at 20 °C, buffer was  corrected by 
subtracting the scan of buffer from the test sample, and an average of three accumulations at a 
scan speed of 200 nm.min-1 were recorded. The samples were excited at 390 nm and emission 
spectra were recorded from 400 to 700 nm. The excitation and emission slit widths were at 5 
nm.    
The ANS binds to the nonpolar regions of the protein and computational docking studies were 
employed to determine specific regions in hGSTP1-1 where ANS binds. The crystal structure 
of the hGSTP1-1 was retrieved from the protein data bank PDB 5J41 and was chosen because 
of its high resolution of 1.19Å (Harshbarger et al., 2017). It was made of the dimer with water 
molecules bound. Protein preparation was then performed on the dimeric structure of the 
hGSTP1-1, this was carried out by removing water molecules, and assigning hydrogen bonds 
to the structure followed by formal charges, ionization and tautomeric states.  The non-
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hydrogen bonds were minimized until they reached an RMSD of 0.3A while the amino acids 
flips were assigned. Induced flexible docking was carried out using Glide software 
(Schrӧdinger LLC 2009, USA). This method was chosen because it allows the ligand to move 
freely, overcoming problems which are usually encountered when the ligand is rigid. A rigid 
ligand typically gives misleading results in conventional docking methods. The induced 
flexible docking is the most effective and accurate method used for predicting ligand binding 
and concomitant structural movements. Induced flexible docking also conforms more closely 
to the shape and binding mode of the ligand. The computational docking studies were run 
overnight and the results were retrieved. The energetically favourable docking score, glide 
energy and glide emodel were retrieved. 
Molecular docking studies have shown ANS to bind the dimer interface of hGSTP1-1. This is 
when the ANS is left to freely bind the region of hGSTP1-1 with highest affinity (Induced fit 
docking). While studies have also shown a possibility of ANS binding to the active site, these 
studies were confirmed untrue with ANS displacement studies. The ANS ligand has 
hydrophobic aniline and naphthyl rings which have been shown to occupy the non-polar H-site 
in some GST proteins such as GSTA1-1 (Dirr et al., 2005). The displacement of ANS by a 
ligand also binding to the H-site from the hGSTP1-1 will give insight on where the ANS binds. 
Ethacrynic acid has been shown to also bind the H-site of hGSTP1-1 and therefore was used 
for the displacement and determination of the binding site of ANS. Fluorescence 
measurements of ANS were performed at 20 ºC and exciting at 390 nm. 
Free ANS has lower fluorescence intensity and an increase is observed when it is bound to the 
hydrophobic regions of hGSTP1-1 (Ghisaidoobe and Chung, 2014). When ANS is displaced 
from the proteins active site a decrease in fluorescence intensity is observed. Fluorescence 
emission was observed at 485 nm. A control run was done where absolute ethanol was titrated 
in a 1ml solution containing 100 µM ANS in a quartz cuvette and 2 µM hGSTP1-1 protein, 
titrations were done from 0 to 6 % ethanol without the presence of ethacrynic acid. The test run 
contained 100 µM ANS and increasing concentrations of ethacrynic acid dissolved in ethanol 
up to 8 mM with 2 µM protein.  
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CHAPTER 3.0: RESULTS 
The hGSTP1-1 wild-type, L159M and T110S SNP recombinant protein forms obtained were 
used for the structural and functional characterisation studies. The purity of the proteins was 
stained with coomasie brilliant blue and visualised using SDS-PAGE and concentrations were 
determined using UV/VIS spectrophotometer followed by structural and biochemical assays. 
3.1 Identification and construction of hGSTP1-1 SNP forms by site directed 
mutagenesis 
Single nucleotide polymorphisms found in hGSTP1-1 were identified from the NCBI website 
(www.ncbi.nlm.nih.gov) (August 2015). The L159M SNP is found in the hydrophobic region 
of domain 2 of the protein in α-helix 6. The T110S SNP is also found in domain 2 and is 
closely positioned next to the Tyr108 found in the active site mainly the H-site of the protein 
which stabilizes the binding of ligands to the active-site. The SNPs were identified on the 
dbSNP (NCBI) data base and the designed T7 primers which were used to incorporate these 
SNPs in hGSTP1-1 sequence. 
 
3.2 Site directed mutagenesis 
Site-directed mutagenesis was performed using polymerase chain reaction (PCR) to 
incorporate the selected nucleotides to form hGSTP1-1 SNP forms: L159M and T110S. The 
diagrams in Figure 3.1A demonstrate sequence alignment of the hGSTP1-1wild-type aligned 
with the L159M and T110S SNP forms retrieved from Blast sequence alignment (NCBI). The 
sequences were visualised using FinchTV application after sequencing at Inqaba Biotech. 
Inqaba Biotech conducted all sequencing to confirm identity of the pET-15b open reading 
frame which encodes for the hGTSP1-1 wild-type, L159M and T110S SNP forms and the 
presence of any other mutations.  The resultant hGSTP1-1 sequence showed 99 % similarity 
for both L159M and T110S SNP forms (Figure 3.1A 1 and 2). A gap was observed which 
could have formed from the fragments which were not sequencing. 
Constructs expressing wild-type hGSTP1-1 and its SNP forms were used to transform cells 
towards recombinant protein production and purification. 
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Figure 3.1A Pairwise sequence alignment of hGSTP1-1 wild-type nucleotides with L159M and T110S SNP forms. Alignment of the L159M 
(1) and T110S (2) with the hGSTP1-1 wild-type yielded 99 % identity. The results show that the incorporation of the mutations into the hGSTP1-
1 wild-type DNA sequence was successful (shown in arrows).  
2 1 
  27 
 
The DNA sequences of the hGSTP1-1 SNP forms were translated into protein sequences and 
aligned with the wild-type. The aligned protein sequences gave identities of 95 % for the 
L159M SNP form and 98 % for the T110S SNP form. The results were run using the Protein 
Basic local alignment search tool (BLAST) (NCBI). The obtained results are shown below in 
Figure 3.1 B and C. 
 
Figure 3.1 B Protein sequence alignment of the wild-type and the L159M SNP. The 
arrow shows the mutation of the Leucine (L) to a Methionine (Met). The methionine is 
written in a three characters while all other proteins are written in one character symbols.  
 
 
Figure 3.1C Protein sequence alignment of the wild-type and the T110S SNP. The arrow 
shows the mutation of a protein from a threonine to a serine.  
 
Score   Identities Positives Gaps 
174 bits(440)   84/88(95%) 86/88(97%) 2/88(2%) 
Query  75   METVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQI  134 
            METVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQI 
Sbjct  1    METVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQI  60 
 
Query  135  SFADYNLLDL--LLIHEVLAPGCLDAFP  160 
            SFADYNLLD+  LLIHEVLAPGCLDAFP 
Sbjct  61   SFADYNLLDMETLLIHEVLAPGCLDAFP  88 
Score   Identities Positives Gaps 
322 bits(826)   158/162(98%) 160/162(98%) 2/162(1%) 
Query  1    METLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTL  60 
            METLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTL 
Sbjct  1    METLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTL  60 
 
Query  61   GLYGKDQQEAALVDMETVNDGVEDLRCKYISLIYSNYEAGKDDYVKALPGQLKPFETLLS  120 
            GLYGKDQQEAALVDMETVNDGVEDLRCKYISLIY+NYEAGKDDYVKALPGQLKPFETLLS 
Sbjct  61   GLYGKDQQEAALVDMETVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLS  120 
 
Query  121  QNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFP  160 
            QNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFP 
Sbjct  121  QNQGGKTFIVGDQISFADYNLLDlLLIHEVLAPGCLDAFP  16 
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3.3 Expression and purification of hGSTP1-1 wild-type and SNP forms 
The proteins were purified using the immobilized metal ion chromatography (IMAC), a 
technique that uses the binding of his-tagged proteins to the positively charged chelating 
agents. Nickel was used as a chelating agent and imidazole was used to elute the protein of 
interest from the column. The elution profiles of hGSTP1-1 wild-type, L159M and T110S SNP 
form UV scans were all observed at A280 nm (blue scans) (Figure 3.2 A,B and C).  The 
purification conditions used for wild-type in Figure 3.2A were also used for the two SNP 
forms in Figure 3.2 B and C. The fractions in peaks shown in red circles were collected and 
stained before visualising on SDS-PAGE (Figure 3.3, 3.4 and 3.5) to confirm if the proteins 
collected were the proteins of interest. 
 
 
Figure 3.2A Immobilised metal-ion chromatography (IMAC) elution profiles of hGSTP1-
1 wild-type. The elution profile of hGSTP1-1 wild-type UV scan was observed at A280 nm 
(blue scan).  The arrow shows a broad peak containing a cocktail of proteins loosely bound to 
the column while the second peak contains the protein eluted as the concentrations of 
imidazole increases. 
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Figure 3.2B Immobilised metal-ion chromatography (IMAC) elution profiles of hGSTP1-
1 L159M SNP form. The first broad UV peak (blue scan) shown by an arrow contains protein 
that have not bound or loosely bound to the column which is washed off with lower 
concentrations of imidazole (green scan) and the peaks shown in red circles represent the target 
protein eluting at higher concentrations of imidazole.  
 
Figure 3.2C Immobilised metal-ion chromatography (IMAC) elution profile of hGSTP1-1 
T110S SNP form. The protein was eluted from the nickel column using an imidazole gradient and the 
collected fractions were analysed using SDS-PAGE. 
 
 
B 
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3.4 SDS-PAGE 
The elution profiles in Figure 3.2 showed presence of proteins which were then analysed 
further by staining with coomasie blue and visualising on SDS-PAGE to confirm purity. The 
SDS-PAGE gel electrophoresis was run with 4 % stacking gel and 16 % separating gel and the 
protein samples were run under reducing conditions. The cells were lysed by sonication before 
purification, however the method used was not very efficient, as there was still a lot of protein 
left in the pellet as shown in the gels below (Figure 3.2, 3.3 and 3.4).  The protein fractions 
were run individually and combined after visualisation (Figure 3.3, 3.5). The combined 
fractions (Figure 3.3 B) showed a presence of low concentrations of contamination twice the 
size of the hGSTP1-1 wild-type monomer. 
 
Figure 3.3 A) SDS-PAGE purification gel for hGSTP1-1 wild-type. The first lane shows the 
Molecular mass marker from Thermo Fisher Scientific, then the Pellet, Supernatant, the Flow through 
and the Wash. Elution contains the protein of interest and the Lanes labelled 1-9 show the fractions 
collected during elution. B) Combined protein fractions obtained from A. The arrow in Figure 3.3A 
B A 
C 
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shows the position of the hGSTP1-1 monomer determined from the graph to be 24.32 kDa, shown with 
a red dot (C). 
. 
 
Figure 3.4 A) SDS-PAGE purification gel for the hGSTP1-1 L159M SNP form. The first 
lane shows the Molecular mass marker, then the Supernatant, and the Pellet as labelled above. 
The lanes following the pellet contains the Flow through, the Wash and the Elution, with the 
protein of interest containing the monomer determined from the graph (B) to be 25.11 kDa.  
A 
B 
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Figure 3.5 A) SDS-PAGE purification gel for hGSTP1-1 T110S SNP form. The first lane 
shows the Molecular mass marker, then the Supernatant, Pellet, Flow through and the Wash. 
Elution contains the protein of interest and the Lanes labelled 1-4 show the fractions collected 
during elution. B) Shows hGSTP1-1 after combining the fractions. The arrow in (A) shows the 
position of the hGSTP1-1 monomer which is 25.7 kDa in size, shown with a red dot in (C).  
 
3.5 Protein concentration determination 
The concentration of the purified protein was determined using a UV/VIS spectrophotometer. 
The proteins were diluted to obtain the same protein concentrations for all the proteins. 
Proteins display a characteristic UV absorption spectrum at approximately 280 nm resulting 
A B 
C 
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from the aromatic amino acid residues such as tyrosine and tryptophan. With the use of the 
known molar extinction co-efficient of the hGSTP1-1, the Beer-Lambert law was use to 
quantitate the amount of the protein by UV absorbance, assuming, from the results obtain from 
the SDS-PAGE that the protein is pure and that there are no UV absorbing non-protein 
components such as bound  nucleotide co-factors, heme or iron- sulfur centres. The peak at 280 
nm suggests the presence of the proteins (Figure 3.6 A) and the serial- dilutions were also 
measured at 280 nm to confirm the concentrations using a different method (Figure. 3.6 B). 
The wild-type, L159M and T110S SNP forms were diluted in such a way that their 
concentrations are the same so that any differences in concentration may be neglected. 
 
 
Figure 3.6 A) Absorbance spectrum of the hGSTP1-1 wild-type, L159M and T110S. B) 
Absorbances of serial dilutions of hGSTP1-1 wild-type measured at 280 nm. The absorbance scans 
of wild-type (blue), L159M (red) and T110S (green) SNP forms were of same concentrations as 
observed at 280 nm. The experimental data was collected in 5 mM sodium phosphate, pH 7.4. 
 The proteins were then used for functional studies and structural studies. 
 
3.6 Structural characterisation 
3.6.1 Secondary structure characterisation using far-UV circular dichroism 
The secondary structure of the purified hGSTP1-1 wild-type protein and SNP forms was 
characterized using circular dichroism spectroscopy. Far-UV circular dichroism (CD) 
A B 
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measurements showed that the secondary structure of the two SNP forms were similar to that 
of wild-type GSTP1-1 measured under identical conditions indicating no structural effects on 
the wild-type hGSTP1-1 protein. The protein remains predominantly alpha-helical even in the 
presence of the SNPs. The experimental data was measured using 2 µM concentrations of the 
protein in 5 mM sodium phosphate, pH 7.4.The results obtained are shown in Figure 3.7 
below. 
 
Figure 3.7 Far-UV CD spectra for the hGSTP1-1 wild-type, L159M and T110S SNP 
forms.  Circular dichroism for the hGSTP1-1 wild-type (blue), the L159M (red) and T110S 
(green) SNP forms showed comparable spectra. They all show troughs at 210 and 220 nm 
wavelength.  
 
3.6.2 Tertiary structure characterisation using fluorescence spectroscopy 
The tertiary structure of the hGSTP1-1 wild-type and the two SNP forms was characterised by 
measuring the fluorescence of the tryptophan residues at 295 nm.  Tryptophans were used as a 
fluorophore for the measurement of fluorescence of the wild-type and SNP forms. This is 
because it has a higher quantum yield as compared to other residues used. The intensity in 
fluorescence of the SNP forms as compared to wild-type will indicate a change in the tertiary 
structure of the protein. The L159M SNP form showed a slightly significant increase in 
fluorescence as compared to the T110S, which showed very low increase in intensity (Figure 
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3.8). The fluorescence spectra results suggest that the two SNPs have an effect on the tertiary 
structure of the hGSTP1-1 protein.  
 
Figure 3.8 Fluorescence spectra of the hGSTP1-1 wild-type, L159M and T110S SNP 
forms. The wild-type (blue), L159M (red) and T110S (green) SNP forms all display emission 
at 350 nm. The L159M SNP form displayed higher fluorescence intensity than the wild-type 
and the T110S SNP form. 
 
3.6.3 Size exclusion chromatography: Quaternary structure analysis 
Size exclusion chromatography was used to investigate the oligomeric state of wild-type 
GSTP1-1, L159M and T110S SNP forms. This technique separates proteins based on their 
molecular size and the separation is achieved as the molecules pass through a gel filtration 
medium packed in a column. Unlike other methods like ion exchange or affinity 
chromatography, molecules do not bind the column so the composition of the buffer does not 
directly affect the degree of separation between peaks and is dependent on the size of the 
molecules and the pores of the matrix in the column. Larger molecules are eluted earlier than 
smaller molecules.  The elution profiles of the proteins displayed no difference in retention 
times suggesting no change in size. Elution profile of wild-type hGSTP1-1 and two SNP forms 
were eluted from the Hi Load™ 16/600 Superdex™ 75 pg column with 20 mM sodium 
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phosphate, pH 7.4, containing 1 mM EDTA and 0.02 % sodium azide. The elution profile of 
the wild-type and the two SNP forms: L159M and T110S are shown in Figure 3.9 below. 
 
Figure 3.9 Elution profiles of wild-type hGSTP1-1, L159M and T110S SNP forms. Wild-
type profile (blue) shows a peak at 55 minutes, with the L159M SNP (red) and T110S SNP 
forms (green) also eluting at 55 minutes. The wild-type and the two SNP forms showed 
shoulders on both sides of the peaks and these peaks were analysed using SDS-PAGE (Figure 
3.10). The wild-type and the ovalbumin peaks also appear to be marginally to the right of the 
L159M and the T110S SNP forms. 
 
To investigate what the shoulders revealed on SEC are, elution samples collected from the 
SEC (Figure 3.10A) were run on SDS-PAGE (B), each peak collected separately.  
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Figure 3.10 A) SDS-PAGE purification gel showing hGSTP1-1 wild-type, L159M and 
T110S after size exclusion chromatography. B) Analysis of wild-type, L159M and T110S 
SNP forms shoulder peaks using SDS-PAGE. The hGSTP1-1 samples (peak 1, 2 and 3) 
were collected from the SEC column (A) and run on SDS-PAGE (B). The hGSTP1-1 wild-
type shows two bands, a very faint band of size 45.0 (1) and a visible band of size 25.0 kDa (2) 
which corresponded to the sizes of the wild-type protein monomer and the band at 45 kDa 
which represents a GST-like contaminant.   
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3.7 Thermal stability studies 
Analysis of CD spectra of proteins as a function of temperature was measured using the 
circular dichroism to determine the thermodynamics of hGSTP1-1, L159M and T110S protein 
folding. The hGSTP1-1 wild-type and the two SNP forms do not refold and therefore the 
thermodynamics could not be determined. The CD spectra of the wild-type and the two SNP 
forms were measured at 222 nm with temperatures varying from 20 to 80 ºC. Experiments 
were performed in 5 mM sodium phosphate buffer at pH 7.4. Concentrations of protein used 
were 2 µM for all proteins. 
The unfolding scan of the proteins is shown in Figure 3.11 below. The proteins all show 
melting at 55 ºC, this result suggests that the SNPs have no influence on the stability of the 
hGSTP1-1. 
 
Figure 3.11 Far-UV CD spectra of the hGSTP1-1 wild-type, L159M, T110S SNP forms as 
a function of temperature at a single wavelength. The wild-type (blue), L159M (red) and 
T110S (green) all showed unfolding at 55 ºC. The stability of the wild-type was not affected by 
the presence of the L159M and T110S SNPs. 
3.8 Functional characterisation of the hGSTP1-1 wild-type and SNP forms 
3.8.1 GST activity assay for hGSTP1-1wild-type and SNP forms 
The catalytic activity of hGSTP1-1 was analysed using the CDNB (1-chloro-2,4- 
dinitrobenzene) assay as described by (Habig et al., 1974). The assay is based upon the GST 
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catalysed reaction between the GSH and the substrate, CDNB.  Cytosolic GSTs catalyse the 
nucleophilic aromatic substitution reaction of CDNB and GSH resulting in the formation of 1-
(s-glutathionyl)-2,4-dintrobenzene (also known as S-2,4 dinitrophenyl glutathione) which 
absorbs light maximally at 340 nm (Habig and Jakoby, 1981). The solid lines on the graphs 
represent a linear fit to the experimental data. The specific activity for each enzyme is 
determined from the slope of the fit with the correlation coefficient of 0.98 for wild-type, 0.97 
and 0.98 for the L159M and T110S SNP forms, respectively. The experimental data was 
collected with varying amounts of protein for the wild-type and the two SNP forms in 100 mM 
sodium phosphate buffer containing 1 mM EDTA and 0.02 % sodium azide at pH 6.5. 
The results obtained showed a decrease in specific activity for T110S SNP form and for 
L159M SNP form (Figure 3.12B and C) when compared to the wild-type (Figure 3.12 A).  
 
Figure 3.12A Specific activity of hGSTP1-1 wild-type. The wild-type shows a specific 
activity of 52.4 µmol/min/mg.  
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Figure 3.12B Specific activity of hGSTP1-1 L159M SNP forms. The presence of the L159M 
SNP in the hGSTP1-1 protein caused a decrease in its activity leading to 22.43 µmol/min/mg. 
The L159M SNP influences the activity of the hGSTP1-1 wild-type protein 
 
Figure 3.12C Specific activity of hGSTP1-1 T110S SNP forms. The T110S SNP form was 
determined to have a specific activity of 43.2 µmol/min/mg which is lower than that of the 
wild-type. 
The percentage activities of the SNP forms were calculated and compared to that of the wild-
type in Table 3.1. 
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Table 3.1 Percentage activities of hGSTP1-1 wild-type, L159M and T110S SNP forms 
 
The specific activity percentages of the wild-type as compared to those of SNP forms differ by 
18 % and 57 % for the T110S and L159M SNP forms, respectively. The T110S does not show 
a significant difference in activity as compared to the wild-type while the L159M SNP form 
shows over 50 % difference.  
The activity of hGSTP1-1 is affected by the presence of SNPs and the binding of ligands to the 
wild-type was investigated to observe how these SNPs affect the structure of the protein and 
further affect ligand binding which may be the reason for the decrease in activity. The results 
obtained from the structural studies, which are the change in tertiary structure presented by the 
increase in fluorescence of the L159M SNP form also indicate an effect caused by the SNP. 
 
3.8.2 ANS binding studies 
The L159M and T110S SNP forms have an effect on the activity of the hGSTP1-1. This led to 
the investigation of whether these SNPs affect ligand binding and the shape or structure of the 
wild-type. ANS was used in this study as a probe to measure the overall surface 
hydrophobicity of the SNP forms relative to the wild-type. The fluorescence properties of ANS 
are fundamentally influenced by the polarity of its surrounding. A shift to a lower wavelength 
of the fluorescence emission maxima is observed when ANS is bound to a hydrophobic surface 
of the protein; this bathochromic shift is accompanied by an increase in fluorescence intensity 
(Slavik, 1982). Experimental data was obtained by incubating 2 µM GSTP1-1 wild-type and 
SNP forms: L159M and T110S separately in 20 mM sodium phosphate buffer, pH 7.4 with 
ANS at a final concentration of 200 µM. ANS was then selectively excited at 390 nm, and 
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emission spectra were measured from 400 to 700 nm. Fluorescence emission spectra of ANS 
bound to hydrophobic regions of hGSTP1-1 wild-type, L159M and T110S SNP forms are 
shown in Figure 3.13. 
 
Figure 3.13 Fluorescence emission spectra of ANS bound to GSTP1-1 wild-type, L159M 
and T110S SNP forms. The hGSTP1-1 wild-type, L159M and T110S had maximum 
fluorescence intensities of 32, 61 and 70 AU, respectively and shifts in wavelength at 486 nm 
for the wild-type (blue), 489 nm for the L159M SNP form (red) and 490 nm for the T110S 
SNP form (green). The fluorescence intensities of the L159M and T110S SNP forms were 
higher as compared to the wild-type. 
3.8.3 Dimer docking studies of ANS to hGSTP1-1 
The regions of protein where the ANS binds may affect the intensity in fluorescence. To 
investigate the possible binding site of the hGSTP1-1, the ANS  was allowed to bind to the 
possible regions in the protein using induced fit docking (flexible docking), and the region of 
the protein with the highest binding affinity for ANS was the dimer interface. The flexible 
docking methodology was employed using Glide software (Shrodinger LLC 2009 USA). ANS 
was allowed to bind freely to the crystal structure of hGSTP1-1.  The two protein subunits  
bind together and form the hGSTP1-1 dimeric complex. The ANS binds to the dimer interface 
in between the subunits, which is the region of the protein with the highest binding affinity for 
ANS as obtained from the studies. The structure of the hGSTP1-1 protein was retrieved from 
the PDB 5J41 along with the 3D structure of the ANS, the results in Figure 3.14 were obtained. 
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Figure 3.14 Diagram illustrating the binding region of ANS in hGSTP1-1. The ANS binds 
in the dimer interface of the hGSTP1-1. 
The ANS did not bind to the active site as expected during computational studies, and was 
shown to bind the dimer interface as shown above. This finding was further proved by 
performing ANS displacement studies in Figure 3.15 below. The image was generated from 
PyMol using the PDB 5J41coordinates. 
3.8.4 ANS Displacement studies 
Computational studies showed that ANS binds to the dimer interface of the protein and thus a 
displacement approach for competitive binding studies was performed, this was investigated 
by performing ANS displacement studies. This method utilizes the potentiometric 1-anilino-8-
naphthalene-sulfonate (ANS). The fluorometer was used to monitor the displaced free ANS 
probe from the binding site on the protein by stepwise addition of the ethacrynic acid. Free 
ANS has low fluorescence intensity and an increase is observed when it is bound to the 
hydrophobic regions of hGSTP1-1. When ANS is displaced from the active site of the protein 
a decrease in fluorescence intensity is observed. Fluorescence measurements were performed 
at 20 ºC and the ANS was exciting at 390 nm. Fluorescence emission was observed at 485 nm. 
Active site 
Subunit 1 Subunit 2 
Dimer interface 
ANS 
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As a control, absolute ethanol was titrated in a 1ml solution containing 100 µM ANS in a 
quartz cuvette and 2 µM hGSTP1-1 protein in 5mM sodium phosphate buffer, pH 6.5. 
Titrations were done from 0 to 6 % ethanol percentage without the presence of ethacrynic acid 
(Figure 3.15A). The test run contained 100 µM ANS and titrations of ethacrynic acid dissolved 
in ethanol to up to 8 mM were done with 2 µM protein (Figure 3.15B). An increase in ethanol 
percentage showed no change and therefore the test run was performed with ethacrynic acid 
dissolved in ethanol (Figure 3.15B).The results obtained are shown in Figure 3.15 A and B 
below. 
 
Figure 3.15 Diagram showing displacement of ANS by ethacrynic acid. A control with 
ethanol showed a straight line (A). There was no displacement of ethacrynic acid from the 
active site observed as the fluorescence of ANS remained constant (B). This suggests that the 
ANS did not bind the active site of the protein. 
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CHAPTER 4: DISCUSSION 
The role of hGSTP1-1 in the detoxification of toxins in humans is very important. This is not 
the only function of the hGSTP1-1 in human but yet the most studied. Other functions of 
hGSTP1-1 include their function as ligandins and their activation of peroxiredoxin VI (Prdx6) 
amongst others. However, factors such as changes in temperature, enzyme or substrate 
concentrations, presence of inhibitors or mutations may affect either its structure or function. 
SNPs have been studied to better understand their effect on the hGSTP1-1 protein and 
therefore comprehend if they cause any diseases to this end, there have been a lot of studies 
done to elucidate the role of SNPs in GSTs and in human health in general. They have been 
implicated in a lot of diseases, most of which are cancers, such as bladder and testicular 
(Harries et al., 1997) and lung cancer (Ryberg et al., 1997).  
4.1 Site directed mutagenesis, expression and purification 
To incorporate SNPs in the hGSTP1-1 wild-type, site directed mutagenesis was performed. 
The experiment was successful as it gave up to 99 % sequence similarity for both L159M and 
T110S SNP forms and the changes in nucleotide were incorporated (Figure 3.1A). A gap 
which might have formed from a fault during sequencing is observed. The alignment of the 
protein sequences was performed and the SNPs resulting in changes in proteins from S to T 
and L to M were incorporated (Figure 3.1 B and C). The expression and purification were also 
successful (Figure 3.2 A, B and C). This result was also confirmed by running SDS-PAGE gels 
to analyse the purified proteins (Figures 3.3, 3.4 and 3.5). A band the size of hGSTP1-1 dimer 
is observed in very low concentrations less than 2 % when observed under densitometry, this 
cannot represent a hGSTP1-1 dimer because the proteins were run under reducing conditions 
and could represent a GST like contaminant as it was able to bind the column. The 
concentrations of the proteins were determined successfully by using absorbance spectrometry 
(Figure 3.6). 
4.2 Influence of mutations on structure: SNPs in the hydrophobic core of hGSTP1-1 
likely to affect structure 
The structure of proteins is made up of building blocks which are amino acids that join 
together to form a secondary structure of the protein which is made up of β-sheets and α-
helices which are organised to form the tertiary structure. Due to the nature of weak 
interactions building up the tertiary structure of proteins, proteins are very sensitive molecules 
and a disruption of its native state by factors such as heat or incorporation of mutations can 
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result in loss of structural integrity. The SNPs in hydrophobic regions play a very important 
role in keeping the structure of the protein stable and maintaining its overall shape and the 
residues making up the active site are important for its function. T110S and L159M SNPs were 
studied to evaluate if they have any effects on the structure and function of hGSTP1-1, 
findings from current study show that these SNPs do not present any effect on the secondary 
structure of hGSTP1-1 (Figure 3.7), as determined in this study by CD.  However they show a 
difference in tertiary structure when compared to the wild-type, as determined by fluorescence 
spectroscopy, with the L159M SNP form showing the most significant difference, as 
demonstrated by is increase in fluorescence intensity (Figure 3.8). The positions of the SNPs 
are shown in Figure 4.1. 
 
Figure 4.1 Locations of the SNPs in hGSTP1-1 hydrophobic core. The position of the 
T110S SNP (yellow) is at the end of the α-helix 4 of the protein while the L159M (red) is 
located inside the hydrophobic core of hGSTP1-1 on α-helix 6. 
Tryptophans were used as fluorophores for measuring fluorescence intensities at 295 nm. The 
hGSTP1-1 contains two tryptophans, Trp28 which has a role in glutathione binding and Trp38 
which is located at the beginning of the second β-strand and is closest to the first part of the C-
terminal helix (Prade et al.,1997). Trp38 is also essential at the G-site of the protein as it 
functions to sequester glutathione. The change in amino acid sequence from leucine to 
methionine is likely to have an effect on the structure of the protein because not only is 
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methionine larger and bulkier it also contains a sulphur atom making it more reactive because 
of its high electronegativity, although it has lower electronegativity than oxygen, the sulphur is 
still likely to form disulfide bonds with other residues in close proximity. The substitution of 
leucine to methionine and the difference in the surface area occupied by methionine is 
illustrated below, with the methionine shown in white and yellow (Figure 4.2). 
 
Figure 4.2 Diagram showing the position of the SNP in position 159 which is substituted 
by a methionine. The methionine is bulkier than the leucine spanning a larger surface area and 
likely to interact with more residues than leucine because of its possession of a sulphur atom 
which makes it more electronegative. 
Leucine 
Leucine 
Methionine 
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The location of methionine, which is the hydrophobic core allows close interaction with other 
residues. The possible interaction of methionine with other residues may have altered its 
structure and because fluorescence of tryptophan is strongly affected by the polarity of its 
surrounding this explains the increased intensity of the L159M SNP form (Figure 3.8). The 
increase in fluorescence can also be attributed to the tryptophans being hidden as a result of the 
change in tertiary structure increasing their quantum yield hence the increase in intensity.   
The SNPs did not display any impact on the quaternary structure (Figure 3.9). The wild-type 
and the two SNP forms eluted at the same time suggesting that their sizes were similar and 
their shape have not been changed. The quaternary interaction of hGSTP1-1 contributes greatly 
towards maintaining the conformation of the protein. It results in the functional conformation 
of the active site (Sternberg et al., 2000, Sayed et al., 2000 and Hornby et al., 2002) and the 
conformational stability of the protein (Dirr and Reinemer, 1991). When the shape or size of 
the protein is altered this may lead to effects such as decreased stability of the protein. 
 
 4.3 Stability of hGSTP1-1  
A number of studies have shown SNPs to affect stability of hGSTP1-1 but the two SNP forms 
T110S and L159M showed no suggestion of an altered stability after evaluation using far-UV 
CD (Figure 3.11). A change in the stability by the T110S SNP is not expected considering the 
position in which it is located at the end of α-helix 4 in the hydrophilic region. It may however 
be expected to have an effect on the function of the protein since it is very closely positioned 
next to a catalytic residue of the H-site which is the Tyr108. The L159M however, even though 
it is buried in the hydrophobic region of the protein was expected to have a role in the stability 
of the protein. The hydrophobic core of hGSTP1-1 has been found to have a role in the folding 
and further influencing the stability of the protein (Dirr et al., 2005). The studies conducted 
however, the findings do not suggest this to be the case. Despite studies of mutations such as 
F151L being done; this mutation is located next to a conserved folding module and in the same 
helix 6 as the L159M SNP form and has been shown to lower stability. The α-helix 6 of 
hGSTP1-1 is predominantly hydrophobic and contains essential conserved features such as the 
N-capping box motif at the beginning of the hydrophobic core of α-helix (Dragani et al., 
1997). The S150A and D153A mutations in this same helix were also shown to be significantly 
more thermolabile when compared to the wild-type demonstrating that the local destabilization 
of the α-helix which is determined by a single capping residue mutation affects the overall 
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stability of the protein (Dragani et al., 1997). The stability of the protein is critical for 
stabilising ligands that bind to it and to the active site; a stable protein will result in efficient 
catalytic function. 
4.4 Function of hGSTP1-1  
The hGSTP1-1 plays a very important role in the regulation of toxins in the body. It 
accomplishes this by conjugating the electrophilic substance to the GSH tripeptide making the 
molecules less toxic and easily excretable from the body (Armstrong, 1991). The hGSTP1-1 
follows the phase 1 drug metabolism reaction which is often catalysed by members of the 
cytochrome p450 supergene family (Klaasen, 1996). The cytochrome p450 enzymes are 
responsible for catalysing the introduction of a functional group such as epoxides into a 
chemically inactive compound. This electrophilic compound allows the reduced GSH which is 
a nucleophile to attack the electrophilic centre of the molecule, and the hGSTP1-1 catalyses 
this reaction. 
The active site of the hGSTP1-1 is made of the G-Site and the H-site, the G-site binds the 
glutathione and the H-site which is half hydrophobic and hydrophilic binds the hydrophobic 
substrates (Reinemer et al., 1992). The H-site is a pocket structure with sidewalls made by 
residues Phe8 and Tyr108. The other two sidewalls are formed by Val38 and Ile104, with the 
bottom built by Val10 and Gly205 (Prade et al., 1997). The active site also spans the domain 
interface with the thioredoxin and C-terminal domains providing better binding for GSH and 
the xenobiotic compound, respectively (Armstrong 1997, Sheehan et al., 2001). In this study, 
the function of the hGSTP1-1 was analysed using the CDNB assay as mentioned above with 
the addition of GSH. The addition of the GSH to the protein allows for the xenobiotic-
conjugates to be noticed and further removed from the cell during phase III drug metabolism. 
This method measures the specific activity of the protein and is highly reliant on an active 
protein. The specific activity of the wild-type was found to be 52.4 µmol/min/mg (Figure 3.12 
A). The T110S SNP form was found to be 43.2 µmol/min/mg (Figure 3.12C) and had 17.7 % 
decrease in activity when compared to the wild-type.  The L159M SNP form had an activity of 
22.4 µmol/min/mg which decreased the activity of the protein by 57.2 % when compared to 
the wild-type (Figure 3.12B). The specific activity of the hGSTP1-1 in literature has been 
shown to be around 40 - 70 µmol/min/mg (Zimniak et al., 1994). The wild-type and the T110S 
SNP form fall in this range but not the L159M SNP form which is significantly low. The 
activity and stability of the protein is very important and the combination of the residues that 
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make it up influences its function.  When the GSH binds the active site it is hydrogen bonded 
via the sulphur atom of the molecule which is located at the N-terminal end of the helix 1. The 
hydrogen bond is donated by the Tyr7 residue and this interaction plays a crucial role in GST 
catalysis by stabilising the activated GSH (GS
-
) (Armstrong, 2002; Abdalla et al., 2002). The 
water molecule that forms the hydrogen bond between the sulfur atom and the Tyr7 also has 
two additional H-bonds to a second water molecule and the main chain nitrogen of Arg13. 
Additionally, the NH-amide of Arg13 is also H-bonded to the Tyr7 (Prade et al., 1997).  
The GSH is also held in place by a second water molecule which is H-bonded to the OH 
oxygen of Tyr108 and this residue further has H-bond contacts to the main chain nitrogen of 
Gly205 and the nitrogen of Asn204. All these h-bonds have distances ranging from 3.0 -3.5 Å  
which represent weak electrostatic bonds. 
Although not known whether there is any interaction between the Tyr108 and the Thr109 
(residue counted excluding the start amino acid), there is a possibility that the residues close to 
the tyrosine also stabilise the tyrosine which also stabilise the binding of the GSH and 
therefore allowing for efficient catalysis. When the threonine is substituted with the serine, 
even though both these amino acids are hydrophilic, denoting that they easily interact with 
surrounding molecules but the threonine still has a larger molecular mass because in has an 
additional hydroxyl making it even more hydrophilic as compared to the serine. This may 
suggest that the threonine has a higher chance of stabilising the surrounding environment than 
the serine hence not much effect is presented on its activity by T110S. 
The L159M SNP form showed an effect on the tertiary structure of the wild-type (Figure 3.8) 
and this may have affected the stability of the residues around the mutation affecting the 
stability of the active site and the residues around it. Such mutations may affect the stability of 
the protein which results in weak interactions of the protein with ligands. 
 
4.5 Influence of mutations on ligand binding  
When ANS is bound to the hydrophobic regions of the protein the fluorescence intensity 
increases. The ligand has been shown to bind the dimer interface of the protein (Figure 3.13). 
Free ANS has lower fluorescence intensity which increases upon binding to hydrophobic 
regions of proteins. The results obtained showed an increase in fluorescence intensity of the 
SNP forms when ANS is bound suggesting that the structure of the SNP forms is slightly 
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changed exposing more hydrophobic regions for ANS to bind. It could also be that the ANS 
binds to the dimer interface (Figure 4.3) of the protein and makes direct contact mostly with 
helix 4 residues.  
 
Figure 4.3 ANS binds to the dimer interface of hGSTP1-1. ANS shows high binding 
affinity for the hydrophobic dimer interface than the active site. The T110S (yellow) and 
L159M (magenta) are positioned in the α-helices with residues closest to the dimer interface 
and likely to interact with the ligand. 
Binding of the ANS to the dimer interface (Figure 4.3) could slightly alter the structure of the 
protein while the protein stabilises its binding and for the reason that the T110S is located in 
the helix 4. The hydrophobic aniline and naphthyl rings of the ANS have been shown to 
occupy the non-polar H-site in GSTA1-1 (Dirr et al., 2005) and this result was also proved to 
be true for the hGSTP1-1 when the ANS was made to dock specifically to the active site, but 
when the flexible docking is performed, where the ligand is freely allowed to bind anywhere 
on the protein. It binds the dimer interface proving that the ANS has higher affinity for the 
dimer interface of the protein than the active site.  The possibility that the ANS can bind to the 
active site of the hGSTP1-1 as it does to that of the Alpha class cannot be ruled out. This idea 
arises from the studies done by Cameron and his group in 1995 on class-Alpha (Cameron et 
al., 1995) and class-Pi studies done by Oakley and his group in 1997 which show these 
proteins in complex with ethacrynic acid drug and it’s GSH-conjugate (Oakley et al., 1997). 
This study demonstrated that the H-site of the Pi- and Alpha-class GSTs bind similar 
Leu159 
Leu159 
Thr110 
Thr110 
ANS 
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compounds distinctly. The ANS displacement studies which were performed to prove that the 
ANS does not bind to the hGSTP1-1 active site were done so using ethacrynic acid. Binding of 
the non-substrate ligand to the GSTs often but not always occur at the dimer interface. The 
possibility of an interaction between the non-substrate ligand binding site and the active site of 
the dimeric protein is interesting 
Studies showed no displacement of ANS from the active site (Figure 3.15) and this could be 
because the ethacrynic acid is a weaker competitor, however binding of ethacrynic acid to the 
H-site has been shown to be favourable for the hGSTP1-1 because it forms a much more 
efficient conjugation reaction in class Pi (Oakley et al., 1997). It binds more deeply in the H-
site forming a direct or indirect hydrogen bond with its acetone oxygen and the H-site, causing 
an increase in electrophilicity of ethacrynic acid β-alkene carbon and therefore more efficient 
conjugation. This also proves how important it is for the protein in its dimeric structure for 
ligandin binding. 
It is not known whether the dimeric structure of hGSTP1-1 is important to the biological 
function of the enzyme, compelling evidence suggests that the dimeric structure improves the 
protein stability and provides the active site with a proper structure for efficient catalysis 
(Armstrong, 2010 & Abdalla et al., 2002, Dirr et al., 1994). 
 
Conclusion 
The decreased activity of hGSTP1-1 by L159M SNP form could cause diseases in human 
because the protein is not functioning fully when the SNP is incorporated to its sequence 
leading to accumulation of toxins in the body, on the other hand it could serve as an advantage 
for cancer patients as it will not cause resistance to cancer drugs. The T110S has no significant 
impact on the protein structure and function and therefore could be a silent mutation without 
any disadvantages. 
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